Bioleaders Corp. | |
Stock Exchange | Korea Exchange |
EPS |
KRW514 |
Market Cap |
KRW229.03 B |
Shares Outstanding |
15.96 M |
Public Float |
11.95 M |
Address |
13 Techno 8-ro Daejeon DE 34028 Korea, Republic Of |
Employees | - |
Website | http://www.bioleaders.co.kr |
Updated | 09/14/2018 |
Bioleaders Corp. is a holding company, which engages in the development of biopharmaceutical products. It operates through following business divisions: Bio-New Treatment and Product. Its products include poly-y-glutamic acid, lactobacillus plantarum BLS41, and skincare products. |